INDV vs LEN · P/E 19, rev $1.19B vs rev $34.19B
Indivior PLC Ordinary Shares (INDV) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Indivior PLC Ordinary Shares (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.
LEN (LEN) common stock.
Latest reported INDV revenue for 2024-12-31 was $1.19B. Net income was $2.0M. Revenue was up 8.7% from 2023-12-31 to 2024-12-31. INDV currently screens at market cap $4.48B and trailing P/E 19.5.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
INDV currently screens at market cap $4.48B and trailing P/E 19.5. LEN currently screens at market cap $0.
Not investment advice. Open the INDV and LEN stock pages for the full models.
Not investment advice.